JP Patent

JP2022501314A — 局所用組成物

Assigned to MC2 Therapeutics Ltd · Expires 2022-01-06 · 4y expired

What this patent protects

本発明は、連続水相、不連続液体油相およびクリサボロールを含む局所適用のための組成物に関する。

USPTO Abstract

本発明は、連続水相、不連続液体油相およびクリサボロールを含む局所適用のための組成物に関する。

Drugs covered by this patent

Benzamycin (BENZOYL PEROXIDE) · Mayne Pharma

Patent Metadata

Patent number: JP2022501314A
Jurisdiction: JP
Classification: —
Expires: 2022-01-06
Drug substance claim: No
Drug product claim: No
Assignee: MC2 Therapeutics Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.